About this trial
Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.
Eligibility criteria
Qualifiers
ESRD (end stage renal disease) patients at BMC (Boston Medical Center)
Receiving hemodialysis
Has a dialysis access malfunction
Undergoing a diagnostic fistulogram for the dialysis access malfunction
Disqualifiers
None
Trial design
Treatments tested in this trial
- Venography
- Intravascular ultrasound (IVUS)
- Image processing
Treatment groups
Sponsors and collaborators
Boston Medical Center
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator